Simbarashe P. Zvada (1), Jan-Stefan Van Der Walt (1,2), Peter J. Smith (1), P Bernard Fourie (3), Giorgio Roscigno (4), Denis Mitchison (5), Ulrika S.H. Simonsson (2), Helen M. McIlleron (1) Effect of Various Meals on the Population Pharmacokinetics of Rifapentine
|
Thu Thuy Nguyen (1), Laurent Massias (2), Gilles Defrance (3), Nadège Bourgeois-Nicolaos (3,4), Xavier Duval (5), France Mentré (1), Antoine Andremont (6,7) and the Linezolid study group Population pharmacokinetic of linezolid in inpatients
|
W Smythe(1), H McIlleron(1), C Merle (2), J Horton(3), P Smith(1), and USH Simonsson(4) A Semi-Mechanistic pharmacokinetic enzyme model for the characterisation of rifampicin pharmacokinetics in South African pulmonary tuberculosis infected adults
|
Bambang Adiwijaya (1), Joshua Henshaw (1), Maria Rosario (1), Holly Kimko (2), Varun Garg (1) Applications of Discrete-Event Dynamic Simulation in HCV Treatment Dynamics
|
N. Jebabli, H. El jebari, E. Gaïes, I. Salouage, S.Trabelsi, M. Lakhal, A. Klouz Population Pharmacokinetics Of Vancomycin In Tunisian Patients
|
Sergey Smirnov (1), Ekaterina Goryacheva (1), Neil Benson (2), Piet Van der Graaf (2), Victoria Flores (3), Oleg Demin (1) Application of systems pharmacology modeling approach to optimize Interferon therapy of hepatitis C
|
Holly Kimko, Donna Skee, Joseph Massarella, Iolanda Cirillo Modeling & Simulation Exercise to Recommend Dosage Regimens for Patients with End-Stage Renal Disease Receiving Hemodialysis
|
T.P.C. Dorlo(1,2), P.J. de Vries(1), J.H. Beijnen(2) and A.D.R. Huitema(2) Optimal Dosing of Miltefosine in Children and Adults with Leishmaniasis
|
Toshihiro Wajima, Ryuji Kubota Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling for Integrase Inhibitors with a Simple Viral Dynamic Model
|
J. Guedj (1), C. Bazzoli (2), A.U. Neumann (3), F. Mentre (2) Design Evaluation and Optimization for models of Hepatitis C viral dynamics
|
Radojka Savic (1,6,9), Bruno Fantin (1,2,3), Andremont Antoine (1,2,8), Laurent Massias (7), Xavier Duval (1,4,5,6), France Mentre (1,4,6) Ciprofloxacin Integrated Plasma, Saliva and Sweat Population Pharmacokinetics and Emergence of Resistance in Human Commensal Bacteria
|
Michael Neely (1), Michael Reed (2), Roger Jelliffe (1) High-dose amoxicillin pharmacokinetics (PK) and pharmacodynamics (PD) in children
|
Elisabet I. Nielsen (1), Otto Cars (2) Lena E. Friberg (1) Pharmacokinetic-Pharmacodynamic Modelling for Antibiotics: Static and Dynamic In Vitro Time-Kill Curve Experiments
|
M. Frank (1), A. Kunz (2), G. Harms (2), JS. Van der Walt (3,4), C. Kloft (1) Population Pharmacokinetic Model Building for Mothers and Newborns using Additional Information from a Different Nevirapine Dataset
|
Seong Bok Jang(1), Min Soo Park(2), Young Goo Song(3), Kyungsoo Park(1) Population Pharmacokinetics of Amikacin in Korean Clinical Population
|
Siv Jönsson(2), Alistair Davidse(1), Justin Wilkins(2,3), Jan-Stefan Van der Walt(1,2), Ulrika SH Simonsson(2), Mats O Karlsson(2), Helen McIlleron(1), Peter Smith(1) Population Pharmacokinetics of Ethambutol in South African Tuberculosis Patients
|
Maria C. Kjellsson(1,4), Veronique Dartois(2), Anne Goh (2), Laura Via(3), Steven Kern(4), Goonaseelan (Colin) Pillai(4) Penetration of Isoniazid, Rifampicin, Pyrazinamide and Moxifloxacin into Pulmonary TB Lesions in Rabbits
|
Isabelle K. Delattre (1), Flora T. Musuamba (1,2), Joakim Nyberg (3), Roger K. Verbeeck (2), Frédérique Jacobs (4), Pierre E. Wallemacq (1) Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin in critically ill septic patients
|
A. Mohamed (1), E.I. Nielsen (1), O. Cars (2) and L.E. Friberg (1). Predictions of Dosing Schedules of Gentamicin in Neonates Based on a Pharmacokinetic/Pharmacodynamic Model Considering Adaptive Resistance
|
J. Tarning(1,2), R. Hoglund(3), P. Chotsiri(1), W. Hanpithakpong(1), A.P. Pyo(4), V. Jullien(5), N. Lindegardh(1,2), M. Rijken(4), I. Adam(6), F. Nosten(1,2,4) Population pharmacokinetics of antimalarial drugs in the treatment of pregnant women with uncomplicated malaria
|
Dalia Khachman (1,2), Jean-Marie Conil (3,4), Bernard Georges (3,4), Sylvie Saivin (2,4), Georges Houin (2) and Celine M. Laffont (1) Population pharmacokinetic analysis of ciprofloxacin in intensive care unit adult patients
|
J.B. Bulitta (1, 3), J. Li (2), A. Poudyal (2), H.H. Yu (2), R.J. Owen (2), B.T. Tsuji (3), R.L. Nation (2), A. Forrest (1, 3) Mechanism-based Modelling of the Synergy of Colistin Combinations against Multidrug-Resistant Gram Negative Bacteria
|
E. Chigutsa(1), H. McIlleron(1), N.H.G. Holford(2) Parallel first order and mixed order elimination of pyrazinamide in South African patients with tuberculosis
|